1. Human α-mannosidase produced in transgenic tobacco plants is processed in human α-mannosidosis cell lines
- Author
-
Francesca, De Marchis, Chiara, Balducci, Andrea, Pompa, Hilde M F, Riise Stensland, Marco, Guaragno, Rita, Pagiotti, Anna R, Menghini, Emanuele, Persichetti, Tommaso, Beccari, and Michele, Bellucci
- Subjects
Mannosidase Deficiency Diseases ,Glycosylation ,Protoplasts ,Fibroblasts ,Plants, Genetically Modified ,Recombinant Proteins ,Cell Line ,Enzyme Activation ,Plant Leaves ,Transformation, Genetic ,alpha-Mannosidase ,Seeds ,Tobacco ,Vacuoles ,Humans ,Immunoprecipitation ,Enzyme Assays ,Plasmids - Abstract
Deficiency in human lysosomal α-mannosidase (MAN2B1) results in α-mannosidosis, a lysosomal storage disorder; patients present a wide range of neurological, immunological, and skeletal symptoms caused by a multisystemic accumulation of mannose-containing oligosaccharides. Here, we describe the expression of recombinant MAN2B1 both transiently in Nicotiana benthamiana leaves and in the leaves and seeds of stably transformed N. tabacum plants. After purification from tobacco leaves, the recombinant enzyme was found to be N-glycosylated and localized in vacuolar compartments. In the fresh leaves of tobacco transformants, MAN2B1 was measured at 10,200 units/kg, and the purified enzyme from these leaves had a specific activity of 32-45 U/mg. Furthermore, tobacco-produced MAN2B1 was biochemically similar to the enzyme purified from human tissues, and it was internalized and processed by α-mannosidosis fibroblast cells. These results strongly indicate that plants can be considered a promising expression system for the production of recombinant MAN2B1 for use in enzyme replacement therapy.
- Published
- 2011